EGRX
Robeco Institutional Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,329
| Closed | -$214K | – | 967 |
|
|
2022
Q1 | $214K | Hold |
4,329
| – | – | ﹤0.01% | 841 |
|
|
2021
Q4 | $220K | Hold |
4,329
| – | – | ﹤0.01% | 836 |
|
|
2021
Q3 | $242K | Hold |
4,329
| – | – | ﹤0.01% | 833 |
|
|
2021
Q2 | $185K | Hold |
4,329
| – | – | ﹤0.01% | 887 |
|
|
2021
Q1 | $180K | Hold |
4,329
| – | – | ﹤0.01% | 884 |
|
|
2020
Q4 | $202K | Hold |
4,329
| – | – | ﹤0.01% | 853 |
|
|
2020
Q3 | $184K | Hold |
4,329
| – | – | ﹤0.01% | 849 |
|
|
2020
Q2 | $208K | Hold |
4,329
| – | – | ﹤0.01% | 886 |
|
|
2020
Q1 | $199K | Hold |
4,329
| – | – | ﹤0.01% | 888 |
|
|
2019
Q4 | $260K | Sell |
4,329
-2,791
| -39% | -$168K | ﹤0.01% | 883 |
|
|
2019
Q3 | $403K | Buy |
7,120
+4,870
| +216% | +$276K | ﹤0.01% | 855 |
|
|
2019
Q2 | $126K | Hold |
2,250
| – | – | ﹤0.01% | 929 |
|
|
2019
Q1 | $114K | Hold |
2,250
| – | – | ﹤0.01% | 925 |
|
|
2018
Q4 | $90K | Hold |
2,250
| – | – | ﹤0.01% | 925 |
|
|
2018
Q3 | $156K | Buy |
+2,250
| New | +$156K | ﹤0.01% | 924 |
|